ʻO Teneligliptin Hydrobromide Intermediate CAS 401564-36-1 Maʻemaʻe >99.5% (HPLC) Hale Hana
Hoʻolako i nā mea waena o Teneligliptin Hydrobromide me ka maʻemaʻe kiʻekiʻe
Teneligliptin Hydrobromide CAS 906093-29-6
1-(3-Methyl-1-Phenyl-5-Pyrazolyl)piperazine CAS 401566-79-8
Teneligliptin Hydrobromide Intermediate CAS 401564-36-1
| Inoa Kimia | (2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester |
| Nā huaʻōlelo like | (S)-tert-Butyl 4-oxo-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate;3-((S)-1-tert-butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl)-1,3-thiazolidine;(2S)-4-oxo-2-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidine-1-carboxylate;ʻO Teneligptin Intermediate B |
| Helu CAS | 401564-36-1 |
| Helu CAT | RF-1818 |
| Kūlana Kūʻai | Ma ka waihona, hoʻonui ʻia a hiki i nā tona |
| ʻĀpana Molekala | C13H20N2O4S |
| Kaumaha Molecular | 300.37 |
| ʻO ka mānoanoa | 1.305 |
| Brand | Kemika Ruifu |
| 'ikamu | Kūlana Nānā | Nā hualoaʻa |
| Ka nana aku | Paʻa keʻokeʻo i ka ʻulaʻula | Hoʻohālike |
| ʻIkepili | IR;HPLC RT | Hoʻohālike |
| Nalo ma ka maloo | <1.00% | 0.20% |
| Na mea pili | ʻO kēlā me kēia haumia hoʻokahi <0.50% | 0.24% |
| Huina haumia <0.50% | 0.39% | |
| Hoʻāʻo | 99.5%~102.0% (Ma ke kumu maloʻo) | 99.8% |
| Maʻemaʻe Enantiomeric | >99.5% | 99.9% |
| Lehu Sulphated | <0.20% | 0.02% |
| Kūlana hoʻāʻo | Kūlana ʻoihana | |
| Hoʻohana | Nā mea waena o Teneligliptin Hydrobromide (CAS: 906093-29-6) | |
Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai
(2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester (CAS: 401564-36-1) he mea waena i hoʻohana ʻia no ka hoʻomākaukau ʻana i ka dipeptidyl peptidase IV (DPP-IV) inhibitor, nā mea waena. o Teneligliptin Hydrobromide (CAS: 906093-29-6).ʻO Teneligliptin kahi mea pale DPP-4 i ʻae ʻia ma Iapana i ka makahiki 2012 no ka mālama ʻana i ka maʻi diabetes type II.Ua ʻike ʻia a hoʻomohala ʻia e Mitsubishi Tanabe Pharma ma lalo o ka inoa kālepa ʻo Tenelia®.E like me nā mea kūʻai aku DPP-4 i kūʻai ʻia, ua ʻae maikaʻi ʻia ʻo Teneligliptin i nā haʻawina āpau a ua hana ʻo QD dosing i kahi hana inhibitory lōʻihi e kūʻē iā DPP-4 a me ka piʻi ʻana o nā pae GLP-1 ikaika, me ka haʻahaʻa haʻahaʻa o ka renal excretion.
